WST) has emerged as the quintessential "picks and shovels" play of this era ... WST announced net sales of $804.6 million, a 7.7% year-over-year increase, and an adjusted diluted EPS of $1.96, crushing analyst estimates.
WST) ... An evolving regulatory backdrop could also slow innovation or client activity ... WST) ... WST) manufactures specialized packaging, containment systems, and delivery devices for injectable drugs and healthcare products ... Eric M ... Medpace (NASDAQ. MEDP) ... IQV).
WST) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.7% year on year to $804.6 million ... Is now the time to buy WST? Find out in our full research report (it’s free for active Edge members).
What Happened? ...WST) jumped 12.3% in the afternoon session after the company reported strong third-quarter 2025 results that surpassed analyst estimates and raised its full-year financial forecast ... More News. ViewMore ... Via MarketBeat ... Via MarketBeat ... .
What Happened? ...WST) jumped 3.1% in the afternoon session after a research note from KeyBanc Capital Markets indicated positive momentum in the bioprocessing sector following an industry conference ... Overall, this quarter could have been better ... .